What improvements would you like in Yahoo! Finance Message Boards? Please send us feedback.
Message Boards Settings Gilead Sciences, Inc. (GILD) - Quote Info
Big upside potential---HIV guildline being reviewed      7-Nov-09 09:14 am    
In a JBS research report, following comments were given:

NIH Office of AIDS Research Advisory Council is currently meeting to discuss “Opportunities for Research Collaborations on HIVAssociated Comorbidities, Coinfections and Complications”. The meeting schedule can be found at www.oar.nih.gov/oarac/meetings.asp.

HIV treatment guidelines for initiation of anti-retroviral therapy may be increased from CD4 levels of 350 cells/mL up to 500 cells/mL, add approximately 100,000 patients in the US and approximately 80,000 patients

If treatment guidelines were updated, we note that this would represent considerable upside to our current HIV franchise estimates.

target price: $61
Rating :
 (1 Rating)
Rate it:
awful/not related to \pooraveragegoodexcellent

mgwqh

Female
Palo Alto, ...


View Messages

Ignore User

Report Abuse

< Previous Message |   Next Message >
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Messages in Topic

Minimum rating: What's this?
  Subject Author Rating Time of Post (ET)  
 
Big upside potential---HIV guildline being reviewed
mgwqh (1 Rating) 7-Nov-09 09:14 am  
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Gilead Sciences Inc. (GILD)

Chart for Gilead Sciences Inc. (GILD)
At 3:29PM ET: 42.94 Down 0.30 (0.69%)
Symbol Lookup